COMMENT : Why French bird in the hand is hard to reject

"Cleaning out the stables is only half the battle. Finding a way forward is the other half"

For Stuart Wallis, chief executive of Fisons, there was always a danger that the long-rumoured bid would emerge before he managed to establish the company with a credible strategy for the future. So it has proved with the hostile pounds 1.7bn offer from Rhone-Poulenc Rorer. When Mr Wallis took over a year ago, Fisons was a company for which it was hard to see a place in the fast-changing world of pharmaceuticals. Too small to justify its substantial and largely undirected research and development facility, it was also too large for the role of niche player. Financially, moreover, the company was slipping into the sea.

The first part of Mr Wallis's brief, to turn the company round and clean it up, is now largely over. Most of the R&D operation and peripheral operations have been sold, production facilities rationalised, and the cost base has been stripped to the bone. With the sale of scientific instruments, the process of transformation will be complete. Already, the achievement is impressive. Even before yesterday's bid, Fisons was one of the year's best-performing shares; the title of "Britain's worst-managed company" with which Fisons was branded a little while back, could hardly seem more inappropriate.

As all chief executives know, however, cleaning out the stables is only half the battle. Finding a way forward is the other half. As things stand, the future continues to look grim.

Patents are expiring, and while the life of some of these products might be extended by the development of enhanced delivery systems, the core business at Fisons is a mature and declining one. Mr Wallis never misses an opportunity to talk about the huge range of opportunities for alliances, link-ups and even full-scale mergers that exist in this industry. However, so far nothing has materialised. Talks with Medeva, one of the most obvious merger candidates and an obvious fit, came to naught. The prospect of finding and cementing the sort of tie-ups that would guarantee a sparkling future within the 60-day timetable of a bid, look remote.

Rhone-Poulenc, moreover, has more reason than most to buy Fisons outright given its existing strength in the respiratory field. The two companies also know each other relatively well through a number of well-established joint venture arrangements. Though Mr Wallis seems intent on fighting to the bitter end, persuading Rhone to up its offer a little may be the better policy. White knights may be hard to come by - three of the most obvious candidates, Astra, Glaxo and Schering-Plough, already have their own competing products either on the market or near to launch. Getting investors to accept his vision of the future may prove equally difficult for Mr Wallis.

Though earnings will rise steeply next year to put an exit multiple of around 16 on the shares - admittedly way below the norm for this sector - this may well mark the high point for Fisons given its declining revenue base. Mr Wallis has developed a good following in the City, but the bird in the hand is always a hard option to reject. In the absence of a white knight, Fisons is going to find it hard to convince investors it is worth much more than Rhone-Poulenc is offering. In France, the fear is that Rhone is overpaying.

A bad week for the private investor

It has not been a good week for the cause of the private investor. The Stock Exchange finally abandoned the rule that obliges a set proportion of all new issues to be reserved for the small shareholder while Crest, the electronic share settlement system to be introduced next year, announced a tariff structure that increases the costs of small transactions.

The effect of both moves is more symbolic than real. The new Crest tariffs make small transactions only marginally more expensive; nor was the Initial Public Offering rule doing much to expand share ownership.

Nonetheless, the impression is of a City that is giving up on the ideal of a share-owning democracy.

To assuage its conscience, the exchange has set up a committee under the City financier, Sir Mark Weinberg, to explore ways of making the private shareholding horse not only come to the water and drink, but keep coming back for more. This is easier said than done, as Sir Mark will tell anyone who cares to listen.

No European country has done more than Britain to trumpet the values of individual share ownership but it doesn't appear to have done any good. Even the privatisation give-aways seem only temporarily to have halted the trend of long-term decline.

Though the number of people holding shares has gone up, the proportion of shares held by private investors has fallen massively. In 1981, 28 per cent of the total value of UK quoted shares was held by individuals. Today, the proportion is down to 18 per cent.

Of those that bought in the privatisations, most took their profits and never returned. It is one thing to be spoon-fed a hyped, sure-bet privatisation stock; quite another to have the confidence to pick one's way through jungles of financial data to bet on a winner. Many people find this daunting, despite the fact that execution-only fees are down to rock bottom.

Instead, the vast majority have taken the easy route of having the choices and the portolio spread decided for them. The explosive growth in unit- linked forms of saving and investment is now the bedrock on which Britain's equity culture is founded. It constitutes a massive public commitment to the equity markets which sets Britain apart from its big continental European partners, and it is a thoroughly modern form of share-owning culture.

There is, however, something unsettling in the thought of an equity environment completely controlled by institutions. Indirect democracy is not the same as the real thing. The recent run of healthily rumbustious AGMs demonstrated that. For this reason above all, Sir Mark's quest deserves every encouragement.

Tomkins' power play backfires in City

When is a share buy-back not a share buyback? When it is announced by Tomkins, the industrial conglomerate, seems to be the answer.

Having announced that it is seeking powers to buy back up to 10 per cent of its shares, Tomkins then went out of its way to explain that it actually has no intention of exercising these powers.

In fact, Tomkins insists, it would not be advantageous to indulge in such an exercise because the money is needed to develop businesses and make acquisitions. Now if the rules were as they are in the United States, where shares can be bought back and kept in Treasury to be issued later if need arises, that would be different.

But they are not; in Britain shares bought back must be cancelled. So if Tomkins has no intention of actually launching a buy-back, why is it seeking powers for one? Just in case, seems to be the answer. Small wonder that dealers are confused.

PROMOTED VIDEO
News
ebookA unique anthology of reporting and analysis of a crucial period of history
Sport
Laura Trott with her gold
Commonwealth Games
Arts and Entertainment
Gal Gadot as Wonder Woman
film
News
Bryan had a bracelet given to him by his late father stolen during the raid
people
Sport
France striker Loic Remy
sportThe QPR striker flew to Boston earlier in the week to complete deal
Extras
indybestSpice up your knife with our selection of delicious toppings
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Training/Learning and Development Coordinator -London

£28000 - £32000 per annum: Ashdown Group: Training/Learning and Development Co...

Training Programme Manager (Learning and Development)-London

£28000 - £32000 per annum + benefits: Ashdown Group: Training Programme Manage...

.NET Software Developer (.NET, C#, ASP.NET, front-end)

£30000 - £45000 per annum: Harrington Starr: A Global Financial Service Organi...

C# Web developer (C#,MVC,ASP.NET,SQL)

£30000 - £40000 per annum + Bonus+Benefits+Package: Harrington Starr: C# Web d...

Day In a Page

A new Russian revolution: Cracks start to appear in Putin’s Kremlin power bloc

A new Russian revolution

Cracks start to appear in Putin’s Kremlin power bloc
Eugene de Kock: Apartheid’s sadistic killer that his country cannot forgive

Apartheid’s sadistic killer that his country cannot forgive

The debate rages in South Africa over whether Eugene de Kock should ever be released from jail
Standing my ground: If sitting is bad for your health, what happens when you stay on your feet for a whole month?

Standing my ground

If sitting is bad for your health, what happens when you stay on your feet for a whole month?
Commonwealth Games 2014: Dai Greene prays for chance to rebuild after injury agony

Greene prays for chance to rebuild after injury agony

Welsh hurdler was World, European and Commonwealth champion, but then the injuries crept in
Israel-Gaza conflict: Secret report helps Israelis to hide facts

Patrick Cockburn: Secret report helps Israel to hide facts

The slickness of Israel's spokesmen is rooted in directions set down by pollster Frank Luntz
The man who dared to go on holiday

The man who dared to go on holiday

New York's mayor has taken a vacation - in a nation that has still to enforce paid leave, it caused quite a stir, reports Rupert Cornwell
Best comedians: How the professionals go about their funny business, from Sarah Millican to Marcus Brigstocke

Best comedians: How the professionals go about their funny business

For all those wanting to know how stand-ups keep standing, here are some of the best moments
The Guest List 2014: Forget the Man Booker longlist, Literary Editor Katy Guest offers her alternative picks

The Guest List 2014

Forget the Man Booker longlist, Literary Editor Katy Guest offers her alternative picks
Jokes on Hollywood: 'With comedy film audiences shrinking, it’s time to move on'

Jokes on Hollywood

With comedy film audiences shrinking, it’s time to move on
It's the best of British art... but not all is on display

It's the best of British art... but not all is on display

Voted for by the British public, the artworks on Art Everywhere posters may be the only place where they can be seen
Critic claims 'I was the inspiration for Blanche DuBois'

Critic claims 'I was the inspiration for Blanche DuBois'

Blanche Marvin reveals how Tennessee Williams used her name and an off-the-cuff remark to create an iconic character
Sometimes it's hard to be a literary novelist

Sometimes it's hard to be a literary novelist

Websites offering your ebooks for nothing is only the latest disrespect the modern writer is subjected to, says DJ Taylor
Edinburgh Fringe 2014: The comedy highlights, from Bridget Christie to Jack Dee

Edinburgh Fringe 2014

The comedy highlights, from Bridget Christie to Jack Dee
Dame Jenny Abramsky: 'We have to rethink. If not, museums and parks will close'

Dame Jenny Abramsky: 'We have to rethink. If not, museums and parks will close'

The woman stepping down as chair of the Heritage Lottery Fund is worried